Longer lives, different economics
Mehta examines healthcare, prevention, longevity and the institutions that pay for them. He asks how better health changes work, family commitments, medical spending and the choices of an ageing electorate.
International discussion circle
A public-health researcher from South Africa; a Japanese ageing specialist; an Indian clinician; a European health economist; an American researcher of medical innovation.
The economic conclusion
Does an intervention reduce lifetime burden or merely add billable activity? Who funds care, and how do benefits change public budgets and voting priorities?
Take part
Watch the discussions, read the sources or bring a question to the character. Direct AI conversations require login and use the shared free allowance or purchased credits.